BioFinance – the annual Ontario biotech jamboree – was held at the Toronto Marriot Hotel from April 6-8, 2010.
The mood was noticeably brighter than last year on account of signs of activity in the M&A field (e.g. Fate Therapeutics had just announced it’s acquisition of Ottawa stem cell startup Verio Therapeutics) and some early stage venture activity (no kidding!).
Here’s a sampling from the sessions, expert panels and company presentations for you to enjoy…
When making an initial pitch to a VC always bear in mind these key points:
Canada’s biotech future
Canada has received a “D” rating for innovation since the early 1980s. We badly need: